Analysis of Motor Performance in Children with Duchene's Muscular Dystrophy

N/ANot Yet RecruitingNCT06750042

Cairo University25 enrolled

Overview

25 boys, ages ranging from 6 to 16 years, diagnosed with Duchene's muscular Dystrophy (DMD) will participated in the study. They will be selected from the Pediatric Rehabilitation Center of Deraya University's outpatient clinic in El-Minia district, Minia-Egypt. The outcome will be assessed motor performance will be assed by Bruininks-Oseretsky Test of Motor Proficiency Second Edition (BOT™-2) : balance, running speed and agility, bilateral coordination and strength and by Blue Cherry; Geratherm Respiratory. It is used to measure vital capacity (VC), forced expired volume in one second (FEV1), FEV1/FVC, FEV1/VC, and peak expiratory flow (PEF) to provide objective information for monitoring lung health.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Duchene's Muscular Dystrophy

Eligibility

Sex: ALLMin age: 6 YearsMax age: 16 Years

Medical Language ↔ Plain English

Inclusion Criteria: * the diagnosis is Duchene's muscular Dystrophy only not other types, * ambulated with or without assistance, * oriented and endurance enough to understand orders to perform ventilation on the Blue Cherry; Geratherm Respiratory device. Exclusion Criteria: * any cognitive or neurological condition (other than Duchene's muscular Dystrophy), * history of previous surgical operations that can affect pulmonary functions, and structural scoliosis

Outcomes

Primary Outcomes

motor performance

respiratory function

respiratory function by Blue Cherry; Geratherm Respiratory. It is used to measure respiratory function to provide objective information for monitoring lung health.

Time frame: measured for only one time